US Stocks
/
Cue Biopharma, Inc. Share Price
Cue Biopharma, Inc. Share Price

Cue Biopharma, Inc. Share Price

NASDAQ: CUE | Mid Cap
$22.16
-$0.28 (-1.25%) Last updated on 09 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Cue Biopharma, Inc. Stock Performance

Open
$21.91
Prev. Close
$22.44
Circuit Range
N/A
Day Range
$21.69 - $22.50
Year Range
$0.17 - $45.21
Volume
2,960
Average Traded
$22.07

Cue Biopharma, Inc. Share Price Today

As of 9 October 2026, Cue Biopharma, Inc.'s share price is $22.16. The stock opened at $21.91, compared to its previous close of $22.44. During today's trading session, Cue Biopharma, Inc.'s share price traded between $21.69 and $22.50, with an average price of $22.09. Over the past 52 weeks, the stock has recorded a high of $45.21 and a low of $0.17. In terms of performance, Cue Biopharma, Inc.'s share price has risen by 50.75% over the last six months and is up 2854.67% on a year-on-year basis.

Cue Biopharma, Inc. Share Price Chart

$21.69$22.50
L
Show Current Price
H

Cue Biopharma, Inc. Stock Fundamentals & Key Indicators

Market Cap
$2.10B
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-22.59
Revenue (TTM)
$27.47B
Return On Equity (TTM)
-7104.24%
Profit Margin
-96.83%
Debt to Equity
0.42
Quarterly Earnings Growth YoY
-1954.63%

Cue Biopharma, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$2.15$21.94$5.69$7.88
Net Profit-$7.45$1.59-$5.18-$153.07
Net Profit Margin-346.51%7.25%-91.04%-1942.51%
Income ChangeN/A121.34%-425.79%-2855.02%

Cue Biopharma, Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$1.25$5.49$9.29$27.47
Net Profit-$53.01-$50.73-$40.67-$26.60
Net Profit Margin-4240.80%-924.04%-437.78%-96.83%
Income ChangeN/A4.30%19.83%34.60%

About Cue Biopharma, Inc.

Cue Biopharma Inc is a clinical-stage therapeutics company focused on advancing a robust portfolio of potentially transformative therapies aimed at enabling functional cures across immunological disorders. Its product pipeline includes CUE-221, an anti-IgE antibody candidate being developed for allergic diseases. The company has also developed the Immuno-STAT platform for targeting disease-related T cells and is developing CUE-401, an IL-2 and TGF-B therapeutic candidate for autoimmune diseases.

Cue Biopharma, Inc. Historical Returns

MonthOpenCloseChange %
Oct 2026
$25.54
$22.48
-13.19%
Sep 2026
$25.51
$25.90
-7.47%
Aug 2026
$27.10
$27.99
+2.90%
Jul 2026
$30.45
$27.20
-12.17%
Jun 2026
$23.15
$30.97
+37.64%
May 2026
$33.25
$22.50
+53.06%
Apr 2026
$0.22
$14.70
+6,521.62%
Mar 2026
$0.28
$0.22
-23.18%
Feb 2026
$0.33
$0.29
-14.24%
Jan 2026
$0.32
$0.34
+10.86%
Dec 2025
$0.61
$0.30
-53.87%
Nov 2025
$0.75
$0.66
-12.13%

CUE Share Price FAQs

What is Cue Biopharma, Inc. share price today?

chevron-up
Cue Biopharma, Inc. share price today is $22.16 as on October 9, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of Cue Biopharma, Inc. stock?

chevron-up
The 52 week high of Cue Biopharma, Inc. stock is $45.21, while the 52 week low is $0.17 as of 9 Oct '26.

What is CUE's market capitalisation today?

chevron-up
CUE market capitalisation is $2.10B as of October 9, 2026, at 6:21 am IST.

What is CUE's net income for the last quarter?

chevron-up
CUE's net income for the last quarter is -153.07B USD.

What is the 5 year returns of CUE?

chevron-up
The 5 year returns of CUE is 81.34% as on 9 Oct '26.

What is the high & low stock price of CUE today?

chevron-up
CUE stock price hit a high of $22.50 and low of $21.69 as of 9 Oct '26.

Can I buy CUE shares in India?

chevron-up
Yes. You can buy CUE in India by opening an international trading account.